Bart Spaetgens

1.1k total citations
37 papers, 527 citations indexed

About

Bart Spaetgens is a scholar working on Surgery, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bart Spaetgens has authored 37 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Nephrology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bart Spaetgens's work include Gout, Hyperuricemia, Uric Acid (10 papers), Hip and Femur Fractures (8 papers) and COVID-19 Clinical Research Studies (6 papers). Bart Spaetgens is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (10 papers), Hip and Femur Fractures (8 papers) and COVID-19 Clinical Research Studies (6 papers). Bart Spaetgens collaborates with scholars based in Netherlands, United States and Belgium. Bart Spaetgens's co-authors include Annelies Boonen, Coen D.A. Stehouwer, An Tran‐Duy, Niek J. de Wit, Arno W. Hoes, José M.A. Wijnands, Lieke E.J.M. Scheepers, Caroline van Durme, Sjef van der Linden and Frank de Vries and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Bart Spaetgens

33 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Spaetgens Netherlands 14 237 129 104 102 90 37 527
Boonphiphop Boonpheng United States 17 122 0.5× 140 1.1× 104 1.0× 99 1.0× 25 0.3× 59 714
Azizullah Beran United States 17 347 1.5× 25 0.2× 195 1.9× 82 0.8× 93 1.0× 149 914
Priya Simoes United States 13 149 0.6× 129 1.0× 99 1.0× 29 0.3× 20 0.2× 30 485
Wim Lemahieu Belgium 12 144 0.6× 58 0.4× 38 0.4× 106 1.0× 13 0.1× 17 654
Dieter Conen Switzerland 12 174 0.7× 33 0.3× 89 0.9× 28 0.3× 23 0.3× 24 658
Kullaya Takkavatakarn Thailand 15 105 0.4× 231 1.8× 64 0.6× 63 0.6× 38 0.4× 51 571
Aparna Saha United States 16 159 0.7× 277 2.1× 217 2.1× 25 0.2× 17 0.2× 33 769
Tarita Murray‐Thomas United Kingdom 13 114 0.5× 150 1.2× 188 1.8× 32 0.3× 11 0.1× 26 991
Chao‐Lun Lai Taiwan 14 143 0.6× 49 0.4× 83 0.8× 26 0.3× 8 0.1× 60 661
Maya K. Rao United States 9 80 0.3× 300 2.3× 77 0.7× 185 1.8× 5 0.1× 15 645

Countries citing papers authored by Bart Spaetgens

Since Specialization
Citations

This map shows the geographic impact of Bart Spaetgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Spaetgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Spaetgens more than expected).

Fields of papers citing papers by Bart Spaetgens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Spaetgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Spaetgens. The network helps show where Bart Spaetgens may publish in the future.

Co-authorship network of co-authors of Bart Spaetgens

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Spaetgens. A scholar is included among the top collaborators of Bart Spaetgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Spaetgens. Bart Spaetgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Sipers, Walther, et al.. (2024). Optimizing Orthogeriatric Hip Fracture Care: Why Fracture Type Matters. Journal of the American Medical Directors Association. 25(10). 105191–105191. 3 indexed citations
5.
Spaetgens, Bart, Wolfgang Bühre, Bart Maesen, et al.. (2024). The Impact of Frailty and Surgical Risk on Health-Related Quality of Life After TAVI. Journal of Cardiovascular Development and Disease. 11(10). 333–333. 1 indexed citations
6.
Haaps, Thijs F. van, Hugo Ten Cate, Marieke J. H. A. Kruip, et al.. (2024). The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study. Age and Ageing. 53(5). 1 indexed citations
7.
Spaetgens, Bart, et al.. (2024). Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals. Drugs & Aging. 41(3). 261–270. 4 indexed citations
8.
Kuy, P.H.M. van der, et al.. (2023). Evaluation of a multifaceted medication review in older patients in the outpatient setting: a before-and-after study. International Journal of Clinical Pharmacy. 45(2). 483–490. 2 indexed citations
9.
Kuy, P.H.M. van der, et al.. (2023). Clinical Decision Support Systems in Hospitalized Older Patients: An Exploratory Analysis in a Real-Life Clinical Setting. Drugs - Real World Outcomes. 10(3). 363–370. 2 indexed citations
10.
Leeuw, Peter W. de, Marjan van den Akker, Jos M. G. A. Schols, et al.. (2022). Control in the Hospital by Extensive Clinical rules for Unplanned hospitalizations in older Patients (CHECkUP); study design of a multicentre randomized study. BMC Geriatrics. 22(1). 36–36. 4 indexed citations
11.
Winkens, Björn, et al.. (2022). Additional value of a triggerlist as selection criterion in identifying patients at high risk of medication-related hospital admission: a retrospective cohort study. International Journal of Clinical Pharmacy. 44(5). 1205–1210. 2 indexed citations
12.
Hanssen, Nordin M.J., Bart Spaetgens, Prabhakara R. Nagareddy, & Andrew Murphy. (2021). DAMPening Mortality in COVID-19. Circulation. 143(10). 971–973. 6 indexed citations
13.
Spaetgens, Bart, et al.. (2021). A flickering cutaneous lesion occurring after an insect bite. SHILAP Revista de lepidopterología. 9(11). e05040–e05040. 1 indexed citations
14.
Mulder, Mark M. G., Jan-Willem E. M. Sels, Renske H. Olie, et al.. (2021). Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation. Frontiers in Cardiovascular Medicine. 8. 654174–654174. 36 indexed citations
15.
Meys, Roy, Jeannet M. Delbressine, Yvonne M.J. Goërtz, et al.. (2020). Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19. Journal of Clinical Medicine. 9(12). 3993–3993. 52 indexed citations
16.
Spaetgens, Bart, Hester A. Gietema, Steffie H. A. Brouns, et al.. (2020). The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison. Thrombosis Research. 196. 486–490. 14 indexed citations
17.
Tran‐Duy, An, Bart Spaetgens, Arno W. Hoes, Niek J. de Wit, & Coen D.A. Stehouwer. (2016). Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 14(12). 1706–1719.e5. 145 indexed citations
18.
Spaetgens, Bart, et al.. (2016). Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice. Clinical Rheumatology. 35(8). 2053–2061. 31 indexed citations
19.
Spaetgens, Bart & Annelies Boonen. (2015). The importance of ‘state-of-the-art’ cost-of-illness studies. Comment on: The economic burden of gout: A systematic review. Seminars in Arthritis and Rheumatism. 45(4). e9–e9. 3 indexed citations
20.
Spaetgens, Bart, José M.A. Wijnands, Caroline van Durme, Sjef van der Linden, & Annelies Boonen. (2014). Cost of Illness and Determinants of Costs Among Patients with Gout. The Journal of Rheumatology. 42(2). 335–344. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boonphiphop Boonpheng Breakdown of academic impact, for papers by Azizullah Beran Breakdown of academic impact, for papers by Priya Simoes Breakdown of academic impact, for papers by Wim Lemahieu Breakdown of academic impact, for papers by Dieter Conen Breakdown of academic impact, for papers by Kullaya Takkavatakarn Breakdown of academic impact, for papers by Aparna Saha Breakdown of academic impact, for papers by Tarita Murray‐Thomas Breakdown of academic impact, for papers by Chao‐Lun Lai Breakdown of academic impact, for papers by Maya K. Rao
Rankless by CCL
2026